Reflux oesophagitis in heavy drinkers: Effect of ranitidine and alginate/metoclopramide

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt

Standard

Reflux oesophagitis in heavy drinkers : Effect of ranitidine and alginate/metoclopramide. / Tønnesen, Hanne; Andersen, Jens Rikardt; Chrisioffersen, Per; Kaas-Claesson, Niels.

I: Digestion, Bind 38, Nr. 2, 1987, s. 69-73.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt

Harvard

Tønnesen, H, Andersen, JR, Chrisioffersen, P & Kaas-Claesson, N 1987, 'Reflux oesophagitis in heavy drinkers: Effect of ranitidine and alginate/metoclopramide', Digestion, bind 38, nr. 2, s. 69-73. https://doi.org/10.1159/000199574

APA

Tønnesen, H., Andersen, J. R., Chrisioffersen, P., & Kaas-Claesson, N. (1987). Reflux oesophagitis in heavy drinkers: Effect of ranitidine and alginate/metoclopramide. Digestion, 38(2), 69-73. https://doi.org/10.1159/000199574

Vancouver

Tønnesen H, Andersen JR, Chrisioffersen P, Kaas-Claesson N. Reflux oesophagitis in heavy drinkers: Effect of ranitidine and alginate/metoclopramide. Digestion. 1987;38(2):69-73. https://doi.org/10.1159/000199574

Author

Tønnesen, Hanne ; Andersen, Jens Rikardt ; Chrisioffersen, Per ; Kaas-Claesson, Niels. / Reflux oesophagitis in heavy drinkers : Effect of ranitidine and alginate/metoclopramide. I: Digestion. 1987 ; Bind 38, Nr. 2. s. 69-73.

Bibtex

@article{56dfc1b33a7e42d8b99acae250dceeb3,
title = "Reflux oesophagitis in heavy drinkers: Effect of ranitidine and alginate/metoclopramide",
abstract = "Of 1, 400 consecutive patients applying to an outpatient clinic for treatment of alcoholism, 477 complained of upper abdominal dyspepsia. After 2 weeks of abstinence, 78 had persisting complaints; of these, 72% had oesophagitis at endoscopy. The 53 patients with oesophagitis as the sole diagnosis were randomized to treatment with either ranitidine or a combination of alginate/antacid chewing tablets and metoclopramide for 6 weeks in a double-blind, double-dummy design. Twenty-five patients left the study during the observation time due to relapse of alcoholism, and were only observed until then. No significant differences were found between the treatment groups concerning the course of symptoms and endoscopic or histological improvement.",
keywords = "Alcoholism, Alginate, Metoclopramide, Oesophagitis, Ranitidine",
author = "Hanne T{\o}nnesen and Andersen, {Jens Rikardt} and Per Chrisioffersen and Niels Kaas-Claesson",
note = "(Ekstern)",
year = "1987",
doi = "10.1159/000199574",
language = "English",
volume = "38",
pages = "69--73",
journal = "Digestion",
issn = "0012-2823",
publisher = "S Karger AG",
number = "2",

}

RIS

TY - JOUR

T1 - Reflux oesophagitis in heavy drinkers

T2 - Effect of ranitidine and alginate/metoclopramide

AU - Tønnesen, Hanne

AU - Andersen, Jens Rikardt

AU - Chrisioffersen, Per

AU - Kaas-Claesson, Niels

N1 - (Ekstern)

PY - 1987

Y1 - 1987

N2 - Of 1, 400 consecutive patients applying to an outpatient clinic for treatment of alcoholism, 477 complained of upper abdominal dyspepsia. After 2 weeks of abstinence, 78 had persisting complaints; of these, 72% had oesophagitis at endoscopy. The 53 patients with oesophagitis as the sole diagnosis were randomized to treatment with either ranitidine or a combination of alginate/antacid chewing tablets and metoclopramide for 6 weeks in a double-blind, double-dummy design. Twenty-five patients left the study during the observation time due to relapse of alcoholism, and were only observed until then. No significant differences were found between the treatment groups concerning the course of symptoms and endoscopic or histological improvement.

AB - Of 1, 400 consecutive patients applying to an outpatient clinic for treatment of alcoholism, 477 complained of upper abdominal dyspepsia. After 2 weeks of abstinence, 78 had persisting complaints; of these, 72% had oesophagitis at endoscopy. The 53 patients with oesophagitis as the sole diagnosis were randomized to treatment with either ranitidine or a combination of alginate/antacid chewing tablets and metoclopramide for 6 weeks in a double-blind, double-dummy design. Twenty-five patients left the study during the observation time due to relapse of alcoholism, and were only observed until then. No significant differences were found between the treatment groups concerning the course of symptoms and endoscopic or histological improvement.

KW - Alcoholism

KW - Alginate

KW - Metoclopramide

KW - Oesophagitis

KW - Ranitidine

UR - http://www.scopus.com/inward/record.url?scp=0023489851&partnerID=8YFLogxK

U2 - 10.1159/000199574

DO - 10.1159/000199574

M3 - Journal article

C2 - 3440508

AN - SCOPUS:0023489851

VL - 38

SP - 69

EP - 73

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 2

ER -

ID: 251991841